-
Mashup Score: 1Clinical Pearls from the 2025 Fall Clinical PA/NP Meeting: Day 1 - 2 hour(s) ago
Jamie Restivo, MPAS, PA-C, shares her key takeaways from the first day of the recent Fall Clinical PA/NP Conference in Orlando, Florida.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0Basics of Rosacea - 3 hour(s) ago
Rosacea is a complex condition that often presents as a combination of subtypes rather than a single distinct form. This discussion highlights the shift from subtype classification to a phenotypic approach, emphasizing individualized treatment strategies that may involve multiple therapies, including medications and procedures, to effectively address patient concerns.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
🌟 Rosacea: Beyond Subtypes Dr Hilary Baldwin explains the shift to a phenotypic model and how it guides personalized rosacea treatment plans. 🎥 Watch now ➤ https://t.co/rlKn9vCfBH #DermTwitter #RosaceaCare #RapidRefresh #HilaryBaldwinMD #PhenotypeFirst
-
-
Mashup Score: 0Diagnosing and Managing GPP: Top Insights From the Experts - 4 hour(s) ago
Aaron Farberg, MD, led a panel exploring the challenges of diagnosing and treating generalized pustular psoriasis and the promise of targeted therapies.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📰 Experts stress early recognition, avoiding steroid withdrawal, and using new targeted treatments like #spesolimab to improve outcomes and quality of life for generalized pustular psoriasis patients. 🖇 Read more: https://t.co/FfSC7N8FRA #GPP
-
-
Mashup Score: 0Journal Digest: June 18, 2025 - 6 hour(s) ago
This review of the latest dermatologic studies includes insights into differences in vitamin D levels in rosacea versus healthy individuals, psychosocial determinants and atopic dermatitis outcomes, and more.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📚 In this week's edition of the Journal Digest, we review the latest dermatologic insights including differences in vitamin D levels in rosacea versus healthy individuals, psychosocial determinants and atopic dermatitis outcomes, and more. https://t.co/2yifUp2YBW #DermTwitter
-
-
Mashup Score: 0
This case series presents the demographic and clinical characteristics as well as laboratory results and treatment outcomes of young patients with eosinophilia and systemic symptoms.
Source: jamanetwork.comCategories: General Medicine News, DermatologyTweet-
This study describes the clinical and laboratory features, management, and long-term outcomes of drug reaction with eosinophilia and systemic symptoms (DRESS) in a cohort of children. https://t.co/04yPGmjYTg https://t.co/BypSxPkuLt
-
-
Mashup Score: 0Home - 14 hour(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
💡 Enhance diabetes care! 📊 Learn to manage DKA, use CGM effectively, & explore the 🧪 latest glucose + ketone monitoring tools. 🔍 Sign up now: https://t.co/Q86SlOttsU #DiabetesCare https://t.co/dEtCN0HN5z
-
-
Mashup Score: 0Home - 17 hour(s) ago
The 18th Annual Hematologic Malignancies Demystified conference returns in 2026. Access our virtual conference and earn CME/CE credits with education from our expert faculty. Led by conference chair, Hagop Kantarjian, MD, and a panel of specialists in the hematology field, each session will give attendees a critical appraisal of the data from 2025 and put that data into clinical context. Educational sessions will spotlight practice-changing data from meetings such as ASH. Our interactive conference center
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
📆 Save the date! The 18th Annual Hematologic Malignancies Demystified returns in 2026. Join virtual CME/CE sessions led by top experts. 👉 https://t.co/UJWM8BT7Tj #HMDlive26 https://t.co/Jbqpyr7YKT
-
-
Mashup Score: 0Maximizing Impact and Utility of Prognostic Gene Testing in Melanoma and Squamous Cell Carcinoma - 20 hour(s) ago
An expert explores how prognostic gene expression testing enhances risk stratification and guides personalized treatment in melanoma and squamous cell carcinoma, and also shares clinical insights and practice pearls from my experience using these tests.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
🎥 Risk stratification is evolving. Learn how gene expression profiling is helping shape melanoma and SCC treatment plans. Watch now: https://t.co/evYuJRv0d2 https://t.co/3Qd1hgkNXH
-
-
Mashup Score: 3A Clinician’s Perspective of RAD 2025: Part 2 - 22 hour(s) ago
At RAD 2025, Maureen Offiah, MD, reflected on the sessions she felt were the most impactful as an attendee.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
👥🎸 At #RAD2025, Maureen Offiah, MD, stressed better recognition and treatment of topical steroid withdrawal, the promise of OX40 inhibitors in #AD, and a push for broader, more holistic approaches. https://t.co/WOSZcU68sE #AtopicDermatitis #DermTwitter
-
-
Mashup Score: 3
Data presented at EULAR 2025 showcased Tremfya’s efficacy as the only IL-23 inhibitor to demonstrate inhibition of this nature in psoriatic arthritis.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📈 New #APEX study data shows #Tremfya (#guselkumab) is the first IL-23 inhibitor to significantly slow joint damage in psoriatic arthritis. #EULAR2025 #PsA https://t.co/8zs2UhC1VW #DermTwitter
-
👥 Jamie Restivo, MPAS, PA-C, shares her key takeaways from the first day of the recent Fall Clinical PA/NP Conference in Orlando, Florida. https://t.co/yO2nKVnZom #DermTwitter